Voya Corporate Leaders 100 Fund I (VYCCX)
24.62
-0.50
(-1.99%)
USD |
Mar 04 2025
Returns Chart
Key Stats
Net Expense Ratio | Total Assets Under Management | Weighted Average Dividend Yield | Turnover Ratio (Generic) |
---|---|---|---|
-- | -- | -- | -- |
1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
-- | -- | Upgrade | Upgrade |
Basic Info
Investment Strategy | |
The Fund seeks to outperform the Standard & Poor's 500 Composite Stock Price Index. Under normal market conditions, the Fund invests primarily in equity securities of issuers listed on the Standard & Poor's 100 Index, a capitalization-weighted index based on 100 highly capitalized stocks for which options are listed. |
General | |
Security Type | Mutual Fund |
Broad Asset Class | US Equity |
Broad Category | Equity |
Global Peer Group | Equity US |
Peer Group | Large-Cap Value Funds |
Global Macro | Equity North America |
US Macro | Large-Cap Funds |
YCharts Categorization | -- |
YCharts Benchmark | -- |
Prospectus Objective | Growth & Income Funds |
Fund Owner Firm Name | Voya |
Broad Asset Class Benchmark Index | |
^SPXTR | 100.0% |
Net Fund Flows Versus Peer Group
1 Month
% Rank:
--
--
Peer Group Low
--
Peer Group High
1 Year
% Rank:
--
--
Peer Group Low
--
Peer Group High
3 Months
% Rank:
--
--
Peer Group Low
--
Peer Group High
3 Years
% Rank:
--
--
Peer Group Low
--
Peer Group High
6 Months
% Rank:
--
--
Peer Group Low
--
Peer Group High
5 Years
% Rank:
--
--
Peer Group Low
--
Peer Group High
YTD
% Rank:
--
--
Peer Group Low
--
Peer Group High
10 Years
% Rank:
--
--
Peer Group Low
--
Peer Group High
Date Unavailable
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of March 05, 2025.
Asset Allocation
As of January 31, 2025.
Type | % Net |
---|---|
Cash | 0.31% |
Stock | 99.49% |
Bond | 0.20% |
Convertible | 0.00% |
Preferred | 0.00% |
Other | 0.00% |
Top 10 Holdings
Name | % Weight | Price | % Change |
---|---|---|---|
CVS Health Corp | 1.23% | 65.94 | 2.69% |
GE Aerospace | 1.16% | 202.41 | 1.83% |
Starbucks Corp | 1.14% | 111.66 | -0.36% |
3M Co | 1.13% | 147.65 | 1.23% |
Meta Platforms Inc | 1.11% | 656.28 | 2.54% |
International Business Machines Corp | 1.11% | 251.35 | -0.73% |
Citigroup Inc | 1.11% | 72.95 | 0.83% |
Thermo Fisher Scientific Inc | 1.10% | 524.27 | 1.49% |
Capital One Financial Corp | 1.09% | 186.05 | 0.62% |
Medtronic PLC | 1.09% | 94.08 | 1.13% |
Fees & Availability
Fees | |
Actual 12B-1 Fee | -- |
Actual Management Fee | 0.37% |
Administration Fee | -- |
Maximum Front Load | -- |
Maximum Deferred Load | -- |
Maximum Redemption Fee | -- |
General Availability | |
Available for Insurance Product | -- |
Available for RRSP | -- |
Purchase Details | |
Open to New Investors |
|
Minimum Initial Investment | 250000.0 None |
Minimum Subsequent Investment | 0.00 None |
Basic Info
Investment Strategy | |
The Fund seeks to outperform the Standard & Poor's 500 Composite Stock Price Index. Under normal market conditions, the Fund invests primarily in equity securities of issuers listed on the Standard & Poor's 100 Index, a capitalization-weighted index based on 100 highly capitalized stocks for which options are listed. |
General | |
Security Type | Mutual Fund |
Broad Asset Class | US Equity |
Broad Category | Equity |
Global Peer Group | Equity US |
Peer Group | Large-Cap Value Funds |
Global Macro | Equity North America |
US Macro | Large-Cap Funds |
YCharts Categorization | -- |
YCharts Benchmark | -- |
Prospectus Objective | Growth & Income Funds |
Fund Owner Firm Name | Voya |
Broad Asset Class Benchmark Index | |
^SPXTR | 100.0% |
Fundamentals
General | |
Distribution Yield | -- |
Dividend Yield TTM | -- |
30-Day SEC Yield | -- |
7-Day SEC Yield | -- |
Stock | |
Weighted Average PE Ratio | -- |
Weighted Average Price to Sales Ratio | -- |
Weighted Average Price to Book Ratio | -- |
Weighted Median ROE | -- |
Weighted Median ROA | -- |
ROI (TTM) | -- |
Return on Investment (TTM) | -- |
Earning Yield | -- |
LT Debt / Shareholders Equity | -- |
Growth Metrics
EPS Growth (1Y) | 18.89% |
EPS Growth (3Y) | 7.97% |
EPS Growth (5Y) | 9.35% |
Sales Growth (1Y) | 3.87% |
Sales Growth (3Y) | 7.52% |
Sales Growth (5Y) | 6.59% |
Sales per Share Growth (1Y) | 4.32% |
Sales per Share Growth (3Y) | 8.42% |
Operating Cash Flow - Growth Ratge (3Y) | 11.50% |
As of January 31, 2025
Fund Details
Key Dates | |
Inception Date | 6/30/2008 |
Last Annual Report Date | 5/31/2024 |
Last Prospectus Date | 9/30/2024 |
Share Classes | |
VYCAX | A |
VYCBX | C |
VYCFX | Retirement |
VYCGX | Retirement |
VYCIX | Other |
Attributes | |
Index Fund | -- |
Inverse Fund | -- |
Leveraged Fund | -- |
Fund of Funds | No |
Currency Hedged Fund | -- |
Synthetic Replication Fund | No |
Top Portfolio Holders
Name | % Weight |
---|---|
Portfolio A | 5.00% |
Portfolio B | 3.50% |
Portfolio C | 2.25% |
Excel Add-In Codes
Name: =YCI("M:VYCCX", "name") |
Broad Asset Class: =YCI("M:VYCCX", "broad_asset_class") |
Broad Category: =YCI("M:VYCCX", "broad_category_group") |
Prospectus Objective: =YCI("M:VYCCX", "prospectus_objective") |
To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |